Medicure (MCUJF) Research & Development (2009 - 2026)
Medicure (MCUJF) posted Research & Development of $439,539 for the quarter ended Jun 30, 2026, down 17.8% from $534,789 a year earlier.
Powered by 
Analysis
Medicure (MCUJF) Research & Development (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Medicure was -$1.53 million; for the year ended Dec 31, 2025, it came in at $2.28 million, up 1.1% from the prior year.
- Annual Research & Development shows a five-year compound annual growth rate of -1.6% (years ended Dec 2020 to Dec 2025).
- In prior years, Medicure's Research & Development was $2.25 million in the year ended Dec 31, 2024 (+26.2%), $1.78 million in the year ended Dec 31, 2023 (-15.8%), $2.12 million in the year ended Dec 31, 2022 (+47.8%) and $1.43 million in the year ended Dec 31, 2021 (-41.8%).
- Quarterly Research & Development has run from a low of -$825,366 in the quarter ended Dec 31, 2025 to a high of $1.04 million in the quarter ended Jun 30, 2022 over five years.
- On a year-over-year basis, Research & Development increased in 1 of the last four quarters, with an average decline of 0.1%.
- The strongest year-over-year quarter for Research & Development in the past five years was the quarter ended Jun 30, 2022, with growth of 81.1%; the weakest was the quarter ended Jun 30, 2023, with a decline of 52.1%.
- According to Business Quant data, Research & Development for the three prior quarters was -$623,471 (quarter ended Mar 31, 2026), -$825,366 (quarter ended Dec 31, 2025) and -$520,997 (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Medicure | 203.51 Mn | 195.32 Mn | 2.31 Mn | 439,538.57 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 439,538.57 |
| Mar 31, 2026 | -623,470.87 |
| Dec 31, 2025 | -825,366.31 |
| Sep 30, 2025 | -520,997.30 |
| Jun 30, 2025 | 534,788.96 |
| Mar 31, 2025 | 397,242.39 |
| Dec 31, 2024 | -531,160.06 |
| Sep 30, 2024 | 582,777.46 |
| Jun 30, 2024 | 634,629.99 |
| Mar 31, 2024 | 501,668.53 |
| Dec 31, 2023 | -566,326.89 |
| Sep 30, 2023 | 378,932.68 |
| Jun 30, 2023 | 497,294.25 |
| Mar 31, 2023 | -389,080.29 |
| Dec 31, 2022 | -567,997.97 |
| Sep 30, 2022 | -240,758.32 |
| Jun 30, 2022 | 1.04 Mn |
| Mar 31, 2022 | 272,369.01 |
| Dec 31, 2021 | 33,320.12 |
| Sep 30, 2021 | 371,783.56 |
API Access
Medicure Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=MCUJF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "MCUJF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=MCUJF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();